Atlas Trials

Neoplasms, Malignant

27 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neoplasms, Malignant

RecordFirmDate
Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid Tumors (NCT06018142)Chinese PLA General Hospital2022-06-01
Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging (NCT04721756)Avid Radiopharmaceuticals2022-04-12
A Phase 1 Dose Escalation and Expansion Study of AK117 (NCT04728334)Akeso2021-03-23
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery (NCT04479579)McMaster University2021-02-22
Clinical Outcomes of NOSES Versus Traditional Robotic-assisted Surgery for Patients With Colorectal Cancer (NCT04230772)Taiyuan Li2021-02-01
Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19 (NCT04637295)University of Nebraska2021-01-27
Existential Distress in Patients with Advanced Cancer and Their Caregivers (NCT04600206)Universitätsklinikum Hamburg-Eppendorf2020-10-23
Thromboembolic Risk Screening in Patients With Cancer and COVID-19 (NCT04616846)Centre Antoine Lacassagne2020-08-04
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104 (NCT04349969)Akesobio Australia Pty Ltd2020-04-23
Cancer Survivors Acute Exercise Response 1 (NCT03903848)University of Houston2019-07-01
EPR Tumor Oximetry With CE India Ink (NCT03321903)Philip Schaner2017-08-30
Oxygen Measurements in Subcutaneous Tumors by EPR Oximetry Using OxyChip (NCT02706197)Periannan Kuppusamy2015-12-31
Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK) (NCT01121588)Pfizer2011-03-22
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027) (NCT01243762)Merck Sharp & Dohme LLC2010-11-22
Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors (NCT01193595)Sanofi2010-09-01
Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors (NCT01095302)Sanofi2010-05-01
Effect of Cabazitaxel on the QTc Interval in Cancer Patients (NCT01087021)Sanofi2010-03-01
Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid Tumors (NCT01021150)Sanofi2010-03-01
A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid Tumor (NCT01063946)Sanofi2010-01-01
Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor (NCT01001221)Sanofi2009-11-01
Radiofrequency Ablation (RFA) Of Tumors Acquired In Childhood (NCT00868647)Seattle Children's Hospital2007-06-01

Track Neoplasms, Malignant automatically

Every clearance here is in the API, with alerts when new ones post.